申请人:Schering Aktiengesellschaft
公开号:US04916144A1
公开(公告)日:1990-04-10
The invention relates to N-substituted imidazoles of the formula, ##STR1## processes for their production as well as their use in pharmaceutical agents. The compounds according to the invention have aromatase-inhibiting properties and are suitable for therapy of estrogen-caused diseases.
本发明涉及公式为 ##STR1## 的N-取代咪唑,其制备过程以及它们在制药剂中的应用。本发明的化合物具有抑制芳香化酶的性质,适用于治疗由雌激素引起的疾病。